Newell Rubbermaid Hosts Analyst Day ATLANTA, Sept. 24, 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Newell Rubbermaid Hosts Analyst Day

ATLANTA, Sept. 24, 2014 (GLOBE NEWSWIRE) -- Newell Rubbermaid Inc. (NYSE: NWL ) will host an Analyst Day today during which it will provide insights into the progress of strategic initiatives to enhance brand development, innovation, marketing and design capabilities and build a robust brand and innovation pipeline for accelerated growth. The company will also provide an update on its Growth Game Plan strategy and financial outlook.

Newell Rubbermaid will reaffirm 2014 guidance, stating that its 2014 core sales growth is tracking to the low end of the guidance range of 3 to 4 percent and normalized EPS is tracking to the high end of the guidance range of $1.94 to $2.00.

During its presentation, the company will also introduce 2015 full year guidance as follows:

Core sales growth 3.5% to 4.0%
   
Currency impact (2.0%) to (2.5%)
   
Impact of acquisitions and divestitures 1.5% to 2.0%
   
Net sales growth 3.0% to 3.5%
   
Normalized EPS $2.16 to $2.22 

The Analyst Day event will be webcast live starting at 9:00 a.m. ET. To access the webcast, please visit Events & Presentations in the Investor Relations section of the Newell Rubbermaid website at www.newellrubbermaid.com . The webcast will be archived and available for replay.

A reconciliation of the 2015 earnings outlook is as follows:

Diluted EPS  $2.02 to $2.10
Restructuring and restructuring-related costs  0.08 to 0.16
Normalized EPS  $2.16 to $2.22

A reconciliation of the 2014 outlook is as follows:

Core sales growth 3% to 4%
   
Currency impact ~(1.5%)
   
Net sales growth 1.5% to 2.5%
   
Diluted EPS  $1.38 to $1.44
Restructuring and restructuring-related costs  0.29 to 0.37
Costs associated with the harness buckle recall  0.03
Currency devaluation – Venezuela  0.09
Inventory charge from the devaluation of the Venezuelan Bolivar  0.01
U.S. pension settlement charge  0.11 to 0.13
Resolution of income tax contingencies   (0.01)
Income from discontinued operations   (0.01)
Normalized EPS  $1.94 to $2.00

Non-GAAP Financial Measures

This release contains non-GAAP financial measures within the meaning of Regulation G promulgated by the Securities and Exchange Commission and includes a reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated in accordance with GAAP. 

The company uses certain financial measures that are included in this press release and the additional financial information both in explaining its results to stockholders and the investment community and in its internal evaluation and management of its businesses. The company's management believes that these measures - including those that are "non-GAAP financial measures" - and the information they provide are useful to investors since these measures (a) permit investors to view the company's performance using the same tools that management uses to evaluate the company's past performance, reportable business segments and prospects for future performance and (b) determine certain elements of management's incentive compensation.

The company's management believes that core sales is useful to investors because it demonstrates the effect of foreign currency on reported sales. The effect of foreign currency on reported sales is determined by applying a fixed exchange rate, calculated as the 12-month average in the preceding year, to the current and prior year local currency sales amounts, with the difference in these two amounts being the change in core sales and the difference between the change in as reported sales and the change in core sales reported as the currency impact.  The company's management believes that "normalized" earnings per share, which also excludes restructuring and restructuring-related charges and one-time events such as losses related to product recalls, asset devaluations resulting from changes in exchange rates in hyperinflationary countries or otherwise, the extinguishments of debt, tax benefits and charges, impairment charges, discontinued operations and certain other items, is useful to investors because it permits investors to better understand year-over-year changes in underlying operating performance. The company also uses core sales and normalized earnings per share as two of the three performance criteria in its management cash bonus plan.

The company determines the tax effect of the items excluded from normalized diluted earnings per share by applying the estimated effective rate for the applicable jurisdiction in which the pre-tax items were incurred, and for which realization of the resulting tax benefit, if any, is expected.

While the company believes that these non-GAAP financial measures are useful in evaluating the company's performance, this information should be considered as supplemental in nature and not as a substitute for or superior to the related financial information prepared in accordance with GAAP. Additionally, these non-GAAP financial measures may differ from similar measures presented by other companies.

About Newell Rubbermaid

Newell Rubbermaid Inc., an S&P 500 company, is a global marketer of consumer and commercial products with 2013 sales of $5.7 billion and a strong portfolio of leading brands, including Sharpie®, Paper Mate®, Rubbermaid Commercial Products®, Irwin®, Lenox®, Parker®, Waterman®, Rubbermaid®, Levolor®, Calphalon®, Goody®, Graco®, Aprica® and Dymo®. As part of the company's Growth Game Plan, Newell Rubbermaid is making sharper portfolio choices and investing in new marketing and innovation to accelerate performance.

This press release and additional information about Newell Rubbermaid are available on the company's Web site, www.newellrubbermaid.com .

Caution Concerning Forward-Looking Statements

Statements in this press release that are not historical in nature constitute forward-looking statements. These forward-looking statements relate to information or assumptions about the effects of sales, income/(loss), earnings per share, operating income, operating margin or gross margin improvements or declines, Project Renewal, capital and other expenditures, cash flow, dividends, restructuring and restructuring-related costs, costs and cost savings, inflation or deflation, particularly with respect to commodities such as oil and resin, debt ratings, changes in exchange rates, product recalls and management's plans, projections and objectives for future operations and performance. These statements are accompanied by words such as "anticipate," "expect," "project," "will," "believe," "estimate" and similar expressions. Actual results could differ materially from those expressed or implied in the forward-looking statements. Important factors that could cause actual results to differ materially from those suggested by the forward-looking statements include, but are not limited to, our dependence on the strength of retail, commercial and industrial sectors of the economy in light of the continuation or escalation of the global economic slowdown or regional sovereign debt issues; currency fluctuations; competition with other manufacturers and distributors of consumer products; major retailers' strong bargaining power; changes in the prices of raw materials and sourced products and our ability to obtain raw materials and sourced products in a timely manner from suppliers; our ability to develop innovative new products and to develop, maintain and strengthen our end-user brands; product liability, product recalls or regulatory actions (including any fines or penalties resulting from governmental investigations into the circumstances related thereto); our ability to expeditiously close facilities and move operations while managing foreign regulations and other impediments; a failure of one of our key information technology systems or related controls; the potential inability to attract, retain and motivate key employees; future events that could adversely affect the value of our assets and require impairment charges; our ability to improve productivity and streamline operations; changes to our credit ratings; significant increases in the funding obligations related to our pension plans due to declining asset values, declining interest rates or otherwise; the imposition of tax liabilities greater than our provisions for such matters; the risks inherent in our foreign operations; the ability of the Company to integrate the acquired businesses with the Company's existing businesses and realize the expected financial results of such transactions; and those factors listed in our most recently filed Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission, and Exhibit 99.1 thereto. Changes in such assumptions or factors could produce significantly different results. The information contained in this news release is as of the date indicated. The company assumes no obligation to update any forward-looking statements contained in this news release as a result of new information or future events or developments.

Nancy O'Donnell Vice President, Investor Relations (770) 418-7723 Nicole Quinlan Senior Manager, Global Communications (770) 418-7251

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Push Notification Security Transforms Healthcare IT Support

Updated Category News Views 1

Cutting the Fat on IT Help Desk Bottlenecks Healthcare IT teams are fighting an uphill battle with password resets, a mundane task consuming up to half of all help desk calls. It's like trying to stop a leaking dam with duct tape. For health systems, these calls aren't just a minor annoyance—they're a full-fledged budget hog. Try telling a CIO that an agent-friendly...

Continue Reading
Aflac's $200M Milestone in Cancer Charity Support

Updated Category News Views 0

Pioneering Efforts Across Decades Here’s an effort that bucks the usual corporate talk. Aflac, the supplemental insurance giant, isn’t just mumbling about its mission; it's doing the heavy lifting in the fight against childhood cancer and blood disorders. With over $200 million in contributions poured into the cause over more than 30 years, they're putting the capital...

Continue Reading
EFSI Shareholders on Alert Amid M&A Deal Scrutiny

Updated Category News Views 3

Eagle Financial Services Under the Microscope A buzz is picking up in the world of mergers and acquisitions, and this time, it's Eagle Financial Services, Inc. (NASDAQ: EFSI) caught in the crosshairs. What's the chatter all about? Well, it looks like Juan Monteverde and his crew over at Monteverde & Associates PC have set their sights on Eagle's proposed sale to John...

Continue Reading
Job Market Shifts: Adaptation vs. Fairness Dilemma

Updated Category News Views 2

The Chameleon Effect in Today's Job Market Walk into any open-space office these days, and you'll see faces plastered with composed, work-ready smiles—faces that might not look so familiar outside those walls. The modern workplace has draped its cloak over individual personalities, with the mighty pressure to 'fit in' often forcing a change in how folks present...

Continue Reading
Give Lively & Change Simplify CA Nonprofit Compliance

Updated Category News Views 0

A Fresh Wind Blowing for California Nonprofits So, here's a twist in the nonprofit world that's stirring the pot just right. Give Lively and Change have partnered up to tackle the thorny issue of regulatory compliance in California. It's a big win for the nonprofits looking to keep fundraising through Give Lively without getting tangled in the bureaucratic web spun up by...

Continue Reading
CUBEX Lights Up Veterinary Care with Mini Essential

Updated Category News Views 5

Inventory Woes? Meet Mini Essential If you’ve ever worked in or around veterinary hospitals, you know the old-school headaches of managing controlled substances. Picture this: piles of paper logs, end-of-shift recounting, and inevitable discrepancies that rear their ugly heads long after closing time. Enter CUBEX, shaking things up with their latest launch, Mini...

Continue Reading
Veho's Role in Redefining Beauty E-Commerce Delivery

Updated Category News Views 1

Veho Grabs Headlines with BeautyMatter Awards Nod Here's something a bit off the beaten path: Veho's been tapping into new wells of opportunity in the e-commerce sector, and their latest accolade demonstrates just that. Named a finalist in the 2026 BeautyMatter Awards under the Logistics category, they're making noise in all the right circles. Beyond Boxes: Transforming...

Continue Reading
Agroz's Big Leap: New Supply Deal in Malaysia

Updated Category News Views 2

Agroz Inc. Executes a Game-Changing Deal If anyone thought the ag tech players were sitting idle, think again. Agroz Inc., noted for their innovative controlled-environment agriculture, just inked a pivotal deal with Harvest Hive in Malaysia. It's not just a nod to expansion—it's a strategic leap into the big leagues. Picture this: Harvest Hive's sprawling 500-acre farm...

Continue Reading
Fresh Thyme Empowers Local Brands in Michigan Debut

Updated Category News Views 2

A Community-Driven Retail Innovation The grocery game just got a little more personal in Michigan, and we're not talking about run-of-the-mill retail pitches. Fresh Thyme Market, known for its commitment to local and natural products, is shaking things up with their Pitch Thyme Competition. This ain’t your usual product presentation. It’s a whole new ball game where...

Continue Reading
Law Firm Gains Strength with Strategic New Hires

Updated Category News Views 0

Catching the latest twist in the legal scene, veteran criminal defense attorney John T. Floyd is stiffening the backbone of his Houston-based firm. Snagging both Christopher Choate and Mia Floyd, he's set to fortify his team representing folks caught in the snarl of Texas and federal criminal courts. New Faces, Massive Expertise Let's dig into Choate's credentials first....

Continue Reading

Top 5 Most Recently Viewed Articles

Alphyn Biologics Launches Groundbreaking Atopic Dermatitis Trial

Updated Category News Views 324

Alphyn Biologics Unveils Innovative Clinical Trial for Atopic Dermatitis Treatment Alphyn Biologics, Inc. is making strides in its mission to address the complexities of atopic dermatitis (AD) by launching the CLEAR-AD1 Phase 2b clinical trial program. Leading this initiative is their cutting-edge product, Zabalafin Hydrogel, which is designed to effectively target the...

Continue Reading
CoreWeave Faces Market Struggles Amid AI Demand Surge

Updated Category News Views 120

CoreWeave Inc Experiences Major Stock Drop CoreWeave Inc (NASDAQ: CRWV) has seen its stock plummet by nearly 10% in pre-market trading, marking a significant moment for the company. The drop comes despite the firm reporting strong second-quarter revenue that outstrips projections. However, the downside appears to be linked to disappointing earnings per share (EPS), which...

Continue Reading
DeepSeek's Impact on AI: Rethinking Market Dynamics

Updated Category News Views 326

Understanding DeepSeek's Revolutionary AI Tools In today's rapidly evolving technological landscape, a recent development has the potential to change the rules of the game. While debates about software consuming the world continue, it's crucial to delve into the implications of DeepSeek's innovative approach. This situation may echo the historical context of the Soviet...

Continue Reading
Strategic Communications Secures Major National Contract

Updated Category News Views 123

Strategic Communications Awarded National Sourcewell Contract Strategic Communications has recently achieved a vital milestone by securing a national Sourcewell contract tailored specifically for Public Safety Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), Platform-as-a-Service (PaaS), and various other professional technology services. This cooperative...

Continue Reading
Porter's Innovative Care Solutions Transform Member Health

Updated Category News Views 312

Porter Simplifying Health Care Coordination Porter has emerged as a pioneering force in AI-driven care coordination and comprehensive clinical services at home. With a focus on Medicare Advantage, ACA Commercial, and Medicaid plans, Porter stands out as an essential in-home vendor. By integrating care coordination, in-home visits, and advanced analytics, this innovative...

Continue Reading